Global Interventional Oncology Market
Report Scope:
The current report highlights the current and future market potential of IO along with a detailed analysis of the competitive environment, regulatory scenario, technology, and the drivers, restraints, opportunities and trends affecting the market. The report also offers market projections to 2026 and market rankings for key players. The report discusses the IO market by type of products, end user and application.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW). North America consists of the U.S., Canada and Mexico. Europe consists of Germany, the U.K., France, and Rest of Europe. Asia-Pacific consists of China, India, Japan and Rest of Asia-Pacific. For market estimates, data has been provided for the 2019 as the base year, 2020 and forecasts for 2026.
Report Includes:
The current report highlights the current and future market potential of IO along with a detailed analysis of the competitive environment, regulatory scenario, technology, and the drivers, restraints, opportunities and trends affecting the market. The report also offers market projections to 2026 and market rankings for key players. The report discusses the IO market by type of products, end user and application.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW). North America consists of the U.S., Canada and Mexico. Europe consists of Germany, the U.K., France, and Rest of Europe. Asia-Pacific consists of China, India, Japan and Rest of Asia-Pacific. For market estimates, data has been provided for the 2019 as the base year, 2020 and forecasts for 2026.
Report Includes:
- 55 data tables and 12 additional tables
- A brief overview of the global market for interventional oncology (IO) as a technology-driven specialty towards cancer intervention
- Analyses of the global market trends, with historic data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global interventional oncology market size, and corresponding market share analysis by product, application, end user and geographic region
- Highlights the current market potential of interventional oncology future directions of the market
- Detailed review of the competitive environment, regulatory scenario, technological advancement, and drivers, restraints, opportunity and trends in market growth
- Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, U.K., France, China, Japan and India
- Competitive landscape of the major players operating within global interventional oncology market, and their global rankings and company share analysis
- Profile descriptions of the leading vendor companies, including Becton, Dickinson and Co. (BD), Boston Scientific Corp., HealthTronics Inc. and Terumo Corp.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market for Interventional Oncology
CHAPTER 3 MEDICAL DEVICE REGULATIONS
Medical Device Definition and Classification
Regulations
U.S.
Europe
Interventional Oncology Devices
CHAPTER 4 INTERVENTIONAL ONCOLOGY: MARKET DYNAMICS
Market Dynamics
Drivers
Restraints
Opportunity
CHAPTER 5 IMPACT OF COVID-19 PANDEMIC
Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology
Collaboration Between Organizations and Governments
Spread of Disease
Current Status and Impact on Medtech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials, and Product Launches
Supply Chain Disruptions
Medical Tourism
Interventional Oncology
CHAPTER 6 MARKET BREAKDOWN BY TYPE OF CANCER
Introduction
Market Size and Forecast
Market Analysis
Liver Cancer
Market Size and Forecast
Market Analysis
Lung Cancer
Market Size and Forecast
Market Analysis
Breast Cancer
Market Size and Forecast
Market Analysis
Kidney Cancer
Market Size and Forecast
Market Analysis
Prostate Cancer
Market Size and Forecast
Market Analysis
Bone Metastasis
Market Size and Forecast
Market Analysis
CHAPTER 7 MARKET BREAKDOWN BY PRODUCT TYPE
Embolization Devices
Market Size and Forecast
Market Analysis
Ablation Devices
Market Size and Forecast
Market Analysis
CHAPTER 8 MARKET BREAKDOWN BY END USER
Hospitals
Market Size and Forecast
Market Analysis
Ambulatory Surgical Centers
Market Size and Forecast
Market Analysis
CHAPTER 9 MARKET BREAKDOWN BY REGION
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Rest of the World
CHAPTER 10 COMPETITIVE LANDSCAPE
Global Company Market Share Analysis
CHAPTER 11 COMPANY PROFILES
BECTON, DICKINSON AND CO.
BOSTON SCIENTIFIC CORP.
COOK MEDICAL INC.
HEALTHTRONICS INC.
JOHNSON & JOHNSON
MEDTRONIC PLC
TERUMO CORP.
CHAPTER 12 APPENDIX: ABBREVIATIONS
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market for Interventional Oncology
CHAPTER 3 MEDICAL DEVICE REGULATIONS
Medical Device Definition and Classification
Regulations
U.S.
Europe
Interventional Oncology Devices
CHAPTER 4 INTERVENTIONAL ONCOLOGY: MARKET DYNAMICS
Market Dynamics
Drivers
Restraints
Opportunity
CHAPTER 5 IMPACT OF COVID-19 PANDEMIC
Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology
Collaboration Between Organizations and Governments
Spread of Disease
Current Status and Impact on Medtech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials, and Product Launches
Supply Chain Disruptions
Medical Tourism
Interventional Oncology
CHAPTER 6 MARKET BREAKDOWN BY TYPE OF CANCER
Introduction
Market Size and Forecast
Market Analysis
Liver Cancer
Market Size and Forecast
Market Analysis
Lung Cancer
Market Size and Forecast
Market Analysis
Breast Cancer
Market Size and Forecast
Market Analysis
Kidney Cancer
Market Size and Forecast
Market Analysis
Prostate Cancer
Market Size and Forecast
Market Analysis
Bone Metastasis
Market Size and Forecast
Market Analysis
CHAPTER 7 MARKET BREAKDOWN BY PRODUCT TYPE
Embolization Devices
Market Size and Forecast
Market Analysis
Ablation Devices
Market Size and Forecast
Market Analysis
CHAPTER 8 MARKET BREAKDOWN BY END USER
Hospitals
Market Size and Forecast
Market Analysis
Ambulatory Surgical Centers
Market Size and Forecast
Market Analysis
CHAPTER 9 MARKET BREAKDOWN BY REGION
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Rest of the World
CHAPTER 10 COMPETITIVE LANDSCAPE
Global Company Market Share Analysis
CHAPTER 11 COMPANY PROFILES
BECTON, DICKINSON AND CO.
BOSTON SCIENTIFIC CORP.
COOK MEDICAL INC.
HEALTHTRONICS INC.
JOHNSON & JOHNSON
MEDTRONIC PLC
TERUMO CORP.
CHAPTER 12 APPENDIX: ABBREVIATIONS
LIST OF TABLES
Summary Table A: Global Market for Interventional Oncology, by Product Type, Through 2026
Summary Table B: Global Market for Interventional Oncology, by Type of Cancer, Through 2026
Summary Table C: Global Market for Interventional Oncology, by End User, Through 2026
Table 1: Class I and Class II Exempt Devices
Table 2: Interventional Oncology Devices
Table 3: Distribution of COVID-19 Clinical Symptoms
Table 4: Total Number of COVID-19 Confirmed Cases and Deaths Worldwide, by Country, October 28, 2021
Table 5: Global Market for Interventional Oncology, by Type of Cancer, Through 2026
Table 6: Global Market for IO Used for Liver Cancer, by Region, Through 2026
Table 7: North American Market for IO Used for Liver Cancer, by Country, Through 2026
Table 8: European Market for IO Used for Liver Cancer, by Country, Through 2026
Table 9: Asia-Pacific Market for IO Used for Liver Cancer, by Country, Through 2026
Table 10: Incidence of Liver Cancer and Associated Deaths, Worldwide, 2020
Table 11: Global Market for IO Used for Lung Cancer, by Region, Through 2026
Table 12: North American Market for IO Used for Lung Cancer, by Country, Through 2026
Table 13: European Market for IO Used for Lung Cancer, by Country, Through 2026
Table 14: Asia-Pacific Market for IO Used for Lung Cancer, by Country, Through 2026
Table 15: Incidence of Lung Cancer and Associated Deaths, Worldwide, 2020
Table 16: Global Market for IO Used for Breast Cancer, by Region, Through 2026
Table 17: North American Market for IO Used for Breast Cancer, by Country, Through 2026
Table 18: European Market for IO Used for Breast Cancer, by Country, Through 2026
Table 19: Asia-Pacific Market for IO Used for Breast Cancer, by Country, Through 2026
Table 20: Incidence of Breast Cancer and Associated Deaths, Worldwide, 2020
Table 21: Global Market for IO Used for Kidney Cancer, by Region, Through 2026
Table 22: North American Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 23: European Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 24: Asia-Pacific Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 25: Global Market for Prostate Cancer, by Region, Through 2026
Table 26: North American Market for Prostate Cancer, by Country, Through 2026
Table 27: European Market for Prostate Cancer, by Country, Through 2026
Table 28: Asia-Pacific Market for Prostate Cancer, by Country, Through 2026
Table 29: Global Market for Bone Metastasis, by Region, Through 2026
Table 30: North American Market for Bone Metastasis, by Country, Through 2026
Table 31: European Market for Bone Metastasis, by Country, Through 2026
Table 32: Asia-Pacific Market for Bone Metastasis, by Country, Through 2026
Table 33: Global Market for Interventional Oncology, by Product Type, Through 2026
Table 34: Global Market for Embolization Devices, by Region, Through 2026
Table 35: North American Market for Embolization Devices, by Country, Through 2026
Table 36: European Market for Embolization Devices, by Country, Through 2026
Table 37: Asia-Pacific Market for Embolization Devices, by Country, Through 2026
Table 38: Global Market for Ablation Devices, by Region, Through 2026
Table 39: North American Market for Ablation Devices, by Country, Through 2026
Table 40: European Market for Ablation Devices, by Country, Through 2026
Table 41: Asia-Pacific Market for Ablation Devices, by Country, Through 2026
Table 42: Global Market for Interventional Oncology, by End User, Through 2026
Table 43: Global Market for Interventional Oncology Used in Hospitals, by Region, Through 2026
Table 44: North American Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 45: European Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 46: Asia-Pacific Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 47: Global Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Region, Through 2026
Table 48: North American Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 49: European Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 50: Asia-Pacific Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 51: Global Market for Interventional Oncology, by Region, Through 2026
Table 52: North American Market for Interventional Oncology, by Country, Through 2026
Table 53: European Market for Interventional Oncology, by Country, Through 2026
Table 54: Asia-Pacific Market for Interventional Oncology, by Country, Through 2026
Table 55: Global Market Share of Interventional Oncology, by Manufacturer, 2020
Table 56: BD: Business Segment
Table 57: BD: Interventional Oncology Product
Table 58: Boston Scientific: Interventional Oncology Product Portfolio
Table 59: Cook Medical: Interventional Oncology Product Portfolio
Table 60: HealthTronics: Interventional Oncology Product Portfolio
Table 61: Johnson & Johnson: Interventional Oncology Product Portfolio
Table 62: Medtronic: Interventional Oncology Product Portfolio
Table 63: Terumo: Interventional Oncology Product Portfolio
Table 64: Abbreviations and Acronyms Used in Interventional Oncology
Summary Table A: Global Market for Interventional Oncology, by Product Type, Through 2026
Summary Table B: Global Market for Interventional Oncology, by Type of Cancer, Through 2026
Summary Table C: Global Market for Interventional Oncology, by End User, Through 2026
Table 1: Class I and Class II Exempt Devices
Table 2: Interventional Oncology Devices
Table 3: Distribution of COVID-19 Clinical Symptoms
Table 4: Total Number of COVID-19 Confirmed Cases and Deaths Worldwide, by Country, October 28, 2021
Table 5: Global Market for Interventional Oncology, by Type of Cancer, Through 2026
Table 6: Global Market for IO Used for Liver Cancer, by Region, Through 2026
Table 7: North American Market for IO Used for Liver Cancer, by Country, Through 2026
Table 8: European Market for IO Used for Liver Cancer, by Country, Through 2026
Table 9: Asia-Pacific Market for IO Used for Liver Cancer, by Country, Through 2026
Table 10: Incidence of Liver Cancer and Associated Deaths, Worldwide, 2020
Table 11: Global Market for IO Used for Lung Cancer, by Region, Through 2026
Table 12: North American Market for IO Used for Lung Cancer, by Country, Through 2026
Table 13: European Market for IO Used for Lung Cancer, by Country, Through 2026
Table 14: Asia-Pacific Market for IO Used for Lung Cancer, by Country, Through 2026
Table 15: Incidence of Lung Cancer and Associated Deaths, Worldwide, 2020
Table 16: Global Market for IO Used for Breast Cancer, by Region, Through 2026
Table 17: North American Market for IO Used for Breast Cancer, by Country, Through 2026
Table 18: European Market for IO Used for Breast Cancer, by Country, Through 2026
Table 19: Asia-Pacific Market for IO Used for Breast Cancer, by Country, Through 2026
Table 20: Incidence of Breast Cancer and Associated Deaths, Worldwide, 2020
Table 21: Global Market for IO Used for Kidney Cancer, by Region, Through 2026
Table 22: North American Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 23: European Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 24: Asia-Pacific Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 25: Global Market for Prostate Cancer, by Region, Through 2026
Table 26: North American Market for Prostate Cancer, by Country, Through 2026
Table 27: European Market for Prostate Cancer, by Country, Through 2026
Table 28: Asia-Pacific Market for Prostate Cancer, by Country, Through 2026
Table 29: Global Market for Bone Metastasis, by Region, Through 2026
Table 30: North American Market for Bone Metastasis, by Country, Through 2026
Table 31: European Market for Bone Metastasis, by Country, Through 2026
Table 32: Asia-Pacific Market for Bone Metastasis, by Country, Through 2026
Table 33: Global Market for Interventional Oncology, by Product Type, Through 2026
Table 34: Global Market for Embolization Devices, by Region, Through 2026
Table 35: North American Market for Embolization Devices, by Country, Through 2026
Table 36: European Market for Embolization Devices, by Country, Through 2026
Table 37: Asia-Pacific Market for Embolization Devices, by Country, Through 2026
Table 38: Global Market for Ablation Devices, by Region, Through 2026
Table 39: North American Market for Ablation Devices, by Country, Through 2026
Table 40: European Market for Ablation Devices, by Country, Through 2026
Table 41: Asia-Pacific Market for Ablation Devices, by Country, Through 2026
Table 42: Global Market for Interventional Oncology, by End User, Through 2026
Table 43: Global Market for Interventional Oncology Used in Hospitals, by Region, Through 2026
Table 44: North American Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 45: European Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 46: Asia-Pacific Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 47: Global Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Region, Through 2026
Table 48: North American Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 49: European Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 50: Asia-Pacific Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 51: Global Market for Interventional Oncology, by Region, Through 2026
Table 52: North American Market for Interventional Oncology, by Country, Through 2026
Table 53: European Market for Interventional Oncology, by Country, Through 2026
Table 54: Asia-Pacific Market for Interventional Oncology, by Country, Through 2026
Table 55: Global Market Share of Interventional Oncology, by Manufacturer, 2020
Table 56: BD: Business Segment
Table 57: BD: Interventional Oncology Product
Table 58: Boston Scientific: Interventional Oncology Product Portfolio
Table 59: Cook Medical: Interventional Oncology Product Portfolio
Table 60: HealthTronics: Interventional Oncology Product Portfolio
Table 61: Johnson & Johnson: Interventional Oncology Product Portfolio
Table 62: Medtronic: Interventional Oncology Product Portfolio
Table 63: Terumo: Interventional Oncology Product Portfolio
Table 64: Abbreviations and Acronyms Used in Interventional Oncology
LIST OF FIGURES
Summary Figure A: Global Market for Interventional Oncology, by Product Type, 2019-2026
Summary Figure B: Global Market for Interventional Oncology, by Type of Cancer, 2019-2026
Summary Figure C: Global Market for Interventional Oncology, by End User, 2019-2026
Figure 1: Process for Marketing a Medical Device in the U.S.
Figure 2: Global Market Share of Interventional Oncology, by Type of Cancer, 2020
Figure 3: Global Market for IO Used for Liver Cancer, 2019-2026
Figure 4: Global Market for IO Used for Lung Cancer, 2019-2026
Figure 5: Global Market for IO Used for Breast Cancer, 2019-2026
Figure 6: Global Market for IO Used for Kidney Cancer, 2019-2026
Figure 7: Global Market for Prostate Cancer, 2019-2026
Figure 8: Global Market for Bone Metastasis, 2019-2026
Figure 9: Global Market Share of Interventional Oncology, by Product Type, 2020
Figure 10: Global Market for Embolization Devices, 2019-2026
Figure 11: Global Market for Ablation Devices, 2019-2026
Figure 12: Global Market Share of Interventional Oncology, by End User, 2020
Figure 13: Global Market for Interventional Oncology Used in Hospitals, 2019-2026
Figure 14: Global Market for Interventional Oncology Used in Ambulatory Surgical Centers, 2019-2026
Figure 15: Global Market Share of Interventional Oncology, by Region, 2020
Figure 16: North American Market Share of Interventional Oncology, by Country, 2020
Figure 17: U.S. Market for Interventional Oncology, 2019-2026
Figure 18: Canadian Market for Interventional Oncology, 2019-2026
Figure 19: Mexican Market for Interventional Oncology, 2019-2026
Figure 20: European Market Share of Interventional Oncology, by Country, 2020
Figure 21: German Market for Interventional Oncology, 2019-2026
Figure 22: Occupational-Related Lung Diseases Share Contributing to Annual Current Deaths in the U.K., 2019
Figure 23: U.K. Market for Interventional Oncology, 2019-2026
Figure 24: French Market for Interventional Oncology, 2019-2026
Figure 25: Rest of European Market for Interventional Oncology, 2019-2026
Figure 26: Asia-Pacific Market Share of Interventional Oncology, by Country, 2020
Figure 27: Japanese Market for Interventional Oncology, 2019-2026
Figure 28: Chinese Market for Interventional Oncology, 2019-2026
Figure 29: Indian Market for Interventional Oncology, 2019-2026
Figure 30: Rest of Asia-Pacific Market for Interventional Oncology, 2019-2026
Figure 31: RoW Market for Interventional Oncology, 2019-2026
Figure 32: BD: Annual Revenue, 2018-2020
Figure 33: BD: Revenue Share, by Business Unit, 2020
Figure 34: BD: Revenue Share, by Region, 2020
Figure 35: Boston Scientific: Annual Revenue, 2018-2020
Figure 36: Boston Scientific: Revenue Share, by Product Category, 2020
Figure 37: Johnson & Johnson: Annual Revenue, 2018 and 2019
Figure 38: Johnson & Johnson: Revenue Share, by Product Category, 2020
Figure 39: Johnson & Johnson: Revenue Share, by Region, 2020
Figure 40: Medtronic: Annual Revenue, 2018-2020
Figure 41: Medtronic: Revenue Share, by Product Category, 2020
Figure 42: Terumo: Annual Revenue, 2018 and 2019
Figure 43: Terumo: Revenue Share, by Product Category, 2019
Summary Figure A: Global Market for Interventional Oncology, by Product Type, 2019-2026
Summary Figure B: Global Market for Interventional Oncology, by Type of Cancer, 2019-2026
Summary Figure C: Global Market for Interventional Oncology, by End User, 2019-2026
Figure 1: Process for Marketing a Medical Device in the U.S.
Figure 2: Global Market Share of Interventional Oncology, by Type of Cancer, 2020
Figure 3: Global Market for IO Used for Liver Cancer, 2019-2026
Figure 4: Global Market for IO Used for Lung Cancer, 2019-2026
Figure 5: Global Market for IO Used for Breast Cancer, 2019-2026
Figure 6: Global Market for IO Used for Kidney Cancer, 2019-2026
Figure 7: Global Market for Prostate Cancer, 2019-2026
Figure 8: Global Market for Bone Metastasis, 2019-2026
Figure 9: Global Market Share of Interventional Oncology, by Product Type, 2020
Figure 10: Global Market for Embolization Devices, 2019-2026
Figure 11: Global Market for Ablation Devices, 2019-2026
Figure 12: Global Market Share of Interventional Oncology, by End User, 2020
Figure 13: Global Market for Interventional Oncology Used in Hospitals, 2019-2026
Figure 14: Global Market for Interventional Oncology Used in Ambulatory Surgical Centers, 2019-2026
Figure 15: Global Market Share of Interventional Oncology, by Region, 2020
Figure 16: North American Market Share of Interventional Oncology, by Country, 2020
Figure 17: U.S. Market for Interventional Oncology, 2019-2026
Figure 18: Canadian Market for Interventional Oncology, 2019-2026
Figure 19: Mexican Market for Interventional Oncology, 2019-2026
Figure 20: European Market Share of Interventional Oncology, by Country, 2020
Figure 21: German Market for Interventional Oncology, 2019-2026
Figure 22: Occupational-Related Lung Diseases Share Contributing to Annual Current Deaths in the U.K., 2019
Figure 23: U.K. Market for Interventional Oncology, 2019-2026
Figure 24: French Market for Interventional Oncology, 2019-2026
Figure 25: Rest of European Market for Interventional Oncology, 2019-2026
Figure 26: Asia-Pacific Market Share of Interventional Oncology, by Country, 2020
Figure 27: Japanese Market for Interventional Oncology, 2019-2026
Figure 28: Chinese Market for Interventional Oncology, 2019-2026
Figure 29: Indian Market for Interventional Oncology, 2019-2026
Figure 30: Rest of Asia-Pacific Market for Interventional Oncology, 2019-2026
Figure 31: RoW Market for Interventional Oncology, 2019-2026
Figure 32: BD: Annual Revenue, 2018-2020
Figure 33: BD: Revenue Share, by Business Unit, 2020
Figure 34: BD: Revenue Share, by Region, 2020
Figure 35: Boston Scientific: Annual Revenue, 2018-2020
Figure 36: Boston Scientific: Revenue Share, by Product Category, 2020
Figure 37: Johnson & Johnson: Annual Revenue, 2018 and 2019
Figure 38: Johnson & Johnson: Revenue Share, by Product Category, 2020
Figure 39: Johnson & Johnson: Revenue Share, by Region, 2020
Figure 40: Medtronic: Annual Revenue, 2018-2020
Figure 41: Medtronic: Revenue Share, by Product Category, 2020
Figure 42: Terumo: Annual Revenue, 2018 and 2019
Figure 43: Terumo: Revenue Share, by Product Category, 2019
